Literature DB >> 1737850

Defective insulin response of phosphorylase phosphatase in insulin-resistant humans.

Y Kida1, I Raz, R Maeda, B L Nyomba, K Stone, C Bogardus, J Sommercorn, D M Mott.   

Abstract

Insulin-stimulated glycogen synthase activity in human muscle is reduced in insulin-resistant subjects. Insulin regulation of human muscle glycogen synthase may require activation of a type-1 protein phosphatase (PP-1). We investigated the change of phosphorylase phosphatase and glycogen synthase activities in muscle biopsies obtained during a 2-h hyperinsulinemic euglycemic clamp in 12 insulin-sensitive (group S) and 8 insulin-resistant (group R) subjects. Fasting phosphorylase phosphatase activity was lower in group R than in group S, and did not increase significantly with insulin infusion in group R until 20 min. In group S, phosphorylase phosphatase was significantly stimulated by 10 min, remaining significantly higher than in group R at all time points. The insulin-mediated changes in phosphatase activities were not decreased by 3 nM okadaic acid but were completely inhibited by 1 microM okadaic acid, thereby verifying that insulin-stimulated phosphorylase phosphatase is accounted for by a PP-1. Subcellular fractionation demonstrated reduced fasting PP-1 activities in both the glycogen and cytosolic fractions of muscle obtained from subjects in group R compared to those in group S. These results suggest that insulin activation of PP-1 could contribute to the stimulation of glycogen synthase by this hormone in human muscle. Lower fasting PP-1 activity in cytosol and glycogen fractions plus lower insulin-stimulated PP-1 activity could explain, in part, reduced insulin-stimulated glycogen synthase in skeletal muscle of insulin-resistant subjects.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1737850      PMCID: PMC442894          DOI: 10.1172/JCI115627

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  45 in total

1.  GLYCOGEN SYNTHETASE ACTIVITY IN SKELETAL MUSCLE. INTERCONVERSION OF TWO FORMS AND CONTROL OF GLYCOGEN SYNTHESIS.

Authors:  W H DANFORTH
Journal:  J Biol Chem       Date:  1965-02       Impact factor: 5.157

2.  The molecular mechanism by which insulin stimulates glycogen synthesis in mammalian skeletal muscle.

Authors:  P Dent; A Lavoinne; S Nakielny; F B Caudwell; P Watt; P Cohen
Journal:  Nature       Date:  1990-11-22       Impact factor: 49.962

3.  An improved procedure for identifying and quantitating protein phosphatases in mammalian tissues.

Authors:  P Cohen; S Klumpp; D L Schelling
Journal:  FEBS Lett       Date:  1989-07-03       Impact factor: 4.124

4.  Inhibitory effect of a marine-sponge toxin, okadaic acid, on protein phosphatases. Specificity and kinetics.

Authors:  C Bialojan; A Takai
Journal:  Biochem J       Date:  1988-11-15       Impact factor: 3.857

5.  Synergistic phosphorylation and activation of ATP-Mg-dependent phosphoprotein phosphatase by F A/GSK-3 and casein kinase II (PC0.7).

Authors:  A A DePaoli-Roach
Journal:  J Biol Chem       Date:  1984-10-10       Impact factor: 5.157

Review 6.  Control of glycogen synthesis in health and disease.

Authors:  W Stalmans; M Bollen; L Mvumbi
Journal:  Diabetes Metab Rev       Date:  1987-01

7.  Drosophila contains three genes that encode distinct isoforms of protein phosphatase 1.

Authors:  V Dombrádi; J M Axton; N D Brewis; E F da Cruz e Silva; L Alphey; P T Cohen
Journal:  Eur J Biochem       Date:  1990-12-27

8.  Glucose-6-phosphate stimulation of human muscle glycogen synthase phosphatase.

Authors:  M Okubo; C Bogardus; S Lillioja; D M Mott
Journal:  Metabolism       Date:  1988-12       Impact factor: 8.694

9.  Deficiency in phosphorylase phosphatase activity despite elevated protein phosphatase type-1 catalytic subunit in skeletal muscle from insulin-resistant subjects.

Authors:  B L Nyomba; D L Brautigan; K K Schlender; W Wang; C Bogardus; D M Mott
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

10.  Identification of members of the protein phosphatase 1 gene family in the rat and enhanced expression of protein phosphatase 1 alpha gene in rat hepatocellular carcinomas.

Authors:  K Sasaki; H Shima; Y Kitagawa; S Irino; T Sugimura; M Nagao
Journal:  Jpn J Cancer Res       Date:  1990-12
View more
  9 in total

1.  Postabsorptive respiratory quotient and insulin-stimulated glucose storage rate in nondiabetic pima indians are related To glycogen synthase fractional activity in cultured myoblasts.

Authors:  D M Mott; R E Pratley; C Bogardus
Journal:  J Clin Invest       Date:  1998-05-15       Impact factor: 14.808

2.  Molecular cloning and chromosomal localization of a human skeletal muscle PP-1 gamma 1 cDNA.

Authors:  S A Norman; D M Mott
Journal:  Mamm Genome       Date:  1994-01       Impact factor: 2.957

3.  Rapid activation of glycogen synthase and protein phosphatase in human skeletal muscle after isometric contraction requires an intact circulation.

Authors:  A Katz; I Raz
Journal:  Pflugers Arch       Date:  1995-12       Impact factor: 3.657

4.  Abnormal regulation of ribosomal protein S6 kinase by insulin in skeletal muscle of insulin-resistant humans.

Authors:  J Sommercorn; R Fields; I Raz; R Maeda
Journal:  J Clin Invest       Date:  1993-02       Impact factor: 14.808

5.  Glycogen synthase: a putative locus for diet-induced hyperglycemia.

Authors:  M F Seldin; D Mott; D Bhat; A Petro; C M Kuhn; S F Kingsmore; C Bogardus; E Opara; M N Feinglos; R S Surwit
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

Review 6.  Pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus: candidates for a signal transmitter defect causing insulin resistance of the skeletal muscle.

Authors:  H U Häring; H Mehnert
Journal:  Diabetologia       Date:  1993-03       Impact factor: 10.122

7.  Oral treatment with vanadium of Zucker fatty rats activates muscle glycogen synthesis and insulin-stimulated protein phosphatase-1 activity.

Authors:  Sabina Semiz; John H McNeill
Journal:  Mol Cell Biochem       Date:  2002-07       Impact factor: 3.396

8.  Palmitate action to inhibit glycogen synthase and stimulate protein phosphatase 2A increases with risk factors for type 2 diabetes.

Authors:  David M Mott; Karen Stone; Mary C Gessel; Joy C Bunt; Clifton Bogardus
Journal:  Am J Physiol Endocrinol Metab       Date:  2007-12-04       Impact factor: 4.310

9.  Deregulation of CREB signaling pathway induced by chronic hyperglycemia downregulates NeuroD transcription.

Authors:  In-Su Cho; Miyoung Jung; Ki-Sun Kwon; Eunpyo Moon; Jang-Hyeon Cho; Kun-Ho Yoon; Ji-Won Kim; Young-Don Lee; Sung-Soo Kim; Haeyoung Suh-Kim
Journal:  PLoS One       Date:  2012-04-03       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.